Smarter Lentiviral Vector Manufacturing for CAR-T | Higher Productivity & Smarter Purification
Watch this on-demand webinar from Virica Biotech and Tozaro on smarter lentiviral vector (LVV) manufacturing for CAR-T, featuring practical upstream and downstream strategies to improve productivity, purification, and process efficiency.
Learn how an integrated approach to lentiviral vector production and purification can help increase LVV yield, improve transduction efficiency, accelerate process development, and reduce cost per dose while remaining compatible with existing adherent and suspension manufacturing platforms.
In this webinar, you’ll learn how to:
- Increase lentiviral vector yield and productivity
- Improve transduction efficiency with lower vector inputs
- Accelerate LVV process development
- Strengthen downstream purification and impurity clearance
- Reduce cost per dose through upstream and downstream optimization
Virica’s VSE™ enhancers demonstrate up to 4× higher LVV yield and up to 3× improved transduction without disrupting your current process.
Tozaro’s Smart Polymer™ affinity ligands support gentle vector capture and release, improved HCP and residual DNA clearance, and scalable lentiviral vector purification.
Explore a smarter approach to CAR-T and cell and gene therapy manufacturing.